Professor Stephen Mackinnon is a Consultant Haematologist at HCA UK at University College Hospital. He specialises in haemato-oncology and has extensive experience in the diagnosis, management and treatment of leukaemia, myeloma and lymphoma.
He attended medical school at the University of Glasgow and then trained in internal medicine and haemato-oncology in Glasgow. He then undertook a transplant fellowship at the Hammersmith Hospital in London where he developed an interest in graft-versus-leukaemia reactions. In 1990 he moved to Memorial Sloan Kettering Cancer Center in New York to continue this work in both the clinic and the lab. His work included making the use of donor lymphocytes less toxic by limiting the T cell dose administered to transplant recipients allowing separation of graft-versus-leukaemia responses from graft-versus-host disease. In 1995 he returned to London to lead the bone marrow and stem cell program at University College London.
In recent years, Professor Mackinnon has developed an interest in novel conditioning regimens. Current research interests include adoptive immunotherapy and immune reconstitution following allogeneic stem cell transplantation, a programme which has resulted in world class transplant outcomes for patients with leukaemia and lymphoma.
Diseases, Medical Tests and Treatments
It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.